静脉注射免疫球蛋白与丙型肝炎流行的相关性１９９４年２月２１日，美国食品与药物管理局通告，３个不同国家有１４例可能由于使用美国加州保健公司生产的一种静注免疫球蛋白（ＩＧＩＶ）产品Ｇａｍｍａｇａｒｄ而发生急性丙型肝炎的病例。于是２３日该公司便从全世界市场... Intravenous immunoglobulin and the prevalence of hepatitis C February 21, 1994, the United States Food and Drug Administration announced that 14 countries in three different countries may be due to the use of a California Health Care Company produced an intravenous immunoglobulin A case of acute hepatitis C in the Gammagard protein (IGIV) product. So the 23rd the company from the world market ...